---
title: "Key facts: Abbott Q1 diagnostics -7.4%; guidance cut; Exact Sciences"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283048446.md"
description: "Abbott (ABT) Q1 sales fell; rapid and molecular diagnostics down 7.4% to $812M, weaker nutrition and diabetes device sales, heart devices lost share to Edwards. Shares fell ~4–6% after outlook cut.1Abbott Laboratories (ABT) Q1 CY2026 adjusted EPS $1.15, in line with estimates. Full-year adjusted EPS guidance cut to $5.48 midpoint, a 3.4% reduction from prior outlook.2Abbott (ABT) says Exact Sciences deal boosted its oncology diagnostics and helped growth; Medical Devices and Established Pharmaceuticals segments showed solid performance.3"
datetime: "2026-04-16T20:07:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283048446.md)
  - [en](https://longbridge.com/en/news/283048446.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283048446.md)
---

# Key facts: Abbott Q1 diagnostics -7.4%; guidance cut; Exact Sciences

-   Abbott (ABT) Q1 sales fell; rapid and molecular diagnostics down 7.4% to $812M, weaker nutrition and diabetes device sales, heart devices lost share to Edwards. Shares fell ~4–6% after outlook cut.1
-   Abbott Laboratories (ABT) Q1 CY2026 adjusted EPS $1.15, in line with estimates. Full-year adjusted EPS guidance cut to $5.48 midpoint, a 3.4% reduction from prior outlook.2
-   Abbott (ABT) says Exact Sciences deal boosted its oncology diagnostics and helped growth; Medical Devices and Established Pharmaceuticals segments showed solid performance.3

### Related Stocks

- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [EXAS.US](https://longbridge.com/en/quote/EXAS.US.md)
- [EW.US](https://longbridge.com/en/quote/EW.US.md)

## Related News & Research

- [Exact Sciences Deal and Legal Pressures Might Change The Case For Investing In Abbott (ABT)](https://longbridge.com/en/news/286516235.md)
- [Harvest Portfolios Group Inc. Grows Holdings in Abbott Laboratories $ABT](https://longbridge.com/en/news/287027124.md)
- [Abbott Laboratories $ABT Shares Purchased by Cambridge Investment Research Advisors Inc.](https://longbridge.com/en/news/286734176.md)
- [NVision Expands from Quantum Sensing to Quantum Computing to Accelerate Discovery and Validation of New Therapies](https://longbridge.com/en/news/286239950.md)
- [Rayburn West Financial Services LLC Buys Shares of 16,587 Abbott Laboratories $ABT](https://longbridge.com/en/news/286395934.md)